13F Pro

SEC Form 4 reporting owner

Kindler Jeffrey B

Kindler Jeffrey B has filed 12 Form 4 transactions reported between December 12, 2025 and August 26, 2026, as Director of PRECIGEN, INC., Director of Praxis Precision Medicines, Inc. and a reporting owner of Terns Pharmaceuticals, Inc..

Name as filed: KINDLER JEFFREY B

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$2.2M
2 lines
Companies
3
with Form 4 filings
Latest transaction
Aug 26, 2026
transaction date

Roles and reported holdings

  • PGENPRECIGEN, INC.
    Dec 12, 2025 – Aug 26, 2026

    Director

    Held directly17,100 sh as of Aug 26, 2026 · Form 4

    24 months: $2.2M sold

  • PRAXPraxis Precision Medicines, Inc.
    Feb 6, 2026 – Jun 10, 2026

    Director

    No common-stock holding reported on a purchase, sale, gift or withholding line.

  • TERNTerns Pharmaceuticals, Inc.
    Feb 1, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 12 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 26, 2026PGENDirectorOpen-market saleCode S · direct185,000$1.4M@ $7.44Form 4
Jun 10, 2026PRAXDirectorGrant or awardCode A · direct648—Form 4
Jun 10, 2026PRAXDirectorGrant or awardCode A · direct1,371—Form 4
Mar 13, 2026PGENDirectorOption exerciseCode M · direct71,839—Form 4
Mar 10, 2026PGENDirectorGrant or awardCode A · direct41,073—Form 4
Mar 10, 2026PGENDirectorGrant or awardCode A · direct35,612—Form 4
Mar 10, 2026PGENDirectorGrant or awardCode A · direct19,658$69K@ $3.51Form 4
Feb 6, 2026PRAXDirectorGrant or awardCode A · direct224—Form 4
Feb 6, 2026PRAXDirectorGrant or awardCode A · direct478—Form 4
Feb 6, 2026PRAXDirectorGrant or awardCode A · direct688—Form 4
Feb 1, 2026TERNGrant or awardCode A · direct1,697—Form 4
Dec 12, 2025PGENDirectorOpen-market saleCode S · direct235,467$856K@ $3.63Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.